Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient care. It is
applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered
exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment
concerning the propriety of any course of conduct must be made by the clinician aer consideration of each
individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated with the
distributor of this clinical reference tool.
Abbreviations
ACE, angiotensin-converting enzyme; ARB, angiotensin-receptor blocker; ARNI,
angiotensin receptor–neprilysin inhibitor; BNP, B-type natriuretic peptide
BP, blood pressure; COR, Class of Recommendation; CPAP, continuous positive airway
pressure; EF, ejection fraction; GDMT, guideline-directed management and therapy;
HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced
ejection fraction; LOE, Level of Evidence; LVEF, le ventricular ejection fraction;
NT-proBNP, N-terminal pro-B-type natriuretic peptide; QoL, quality of life; RCT,
randomized controlled trial
Source
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos
GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE,
Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA focused update of the
2013 ACCF/AHA guideline for the management of heart failure: a report of the American
College of Cardiolog y/American Heart Association Task Force on Clinical Practice Guidelines
and the Heart Failure Society of America. Circulation. 2017;000:e000–e000. DOI: 10.1161/
CIR.0000000000000509.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2017 All rights reserved
ACCHEAupdate1792a 10/17 PP-US-IRON-0028
